68252-28-8

68252-28-8 structure

Name: (R)-Oxiracetam
Chemical Name: (R)-oxiracetam
CAS Number: 68252-28-8
Molecular Formula: C₆H₁₀N₂O₃
Molecular Weight: 158.155
Catalog: Research Areas Neurological Disease
Create Date: 2018-05-13 07:34:29
Modify Date: 2025-08-20 12:42:55
(R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam. Oxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.IC50 value:Target: nootropic drugOxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.[1][2] Several animal studies suggest that the substance is safe even when high doses are consumed for a long period of time.[medical citation needed] However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States.

Name	(R)-oxiracetam
Synonyms	2-[(4R)-4-hydroxy-2-oxopyrrolidin-1-yl]acetamide 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo- 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide UNII:P7U817352G (R)-2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide 2-(4-Hydroxypyrrolidin-2-on-1-yl)acetamide L-oxiracetam oxiracetam (R)-4-hydroxy-2-oxopyrrolidineacetamide (R)-4-hydroxy-2-oxo-1-pyrrolidineacetamide R-oxiracetam 2-[(4R)-4-Hydroxy-2-oxo-1-pyrrolidinyl]acetamide 2-(4-Hydroxy-2-oxo-1-pyrrolidinyl)acetamide 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (4R)- (4R)-(+)-oxiracetam

Description	(R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam. Oxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.IC50 value:Target: nootropic drugOxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.[1][2] Several animal studies suggest that the substance is safe even when high doses are consumed for a long period of time.[medical citation needed] However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States.
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease
References	[1]. Malykh AG, et al. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs. 2010 Feb 12;70(3):287-312. [2]. Valzelli L, et al. Difference in learning and retention by Albino Swiss mice. Part III. Effect of some brain stimulants. Methods Find Exp Clin Pharmacol. 1986 Jun;8(6):337-41.